http://www.acc.org/Feed?clinicalTopicID=5f25c4ac-b76f-4970-a93c-15cdf264bed5 Clinical Topic Feed: Dyslipidemia en /Latest-in-Cardiology/Articles/2026/05/07/15/36/ai-enabled-clinician-07may2026 In this episode, Chief Innovation Officer, Ami Bhatt, MD, FACC and Allen Taylor, MD, FACC discuss the importance of cardiovascular prevention and early screening through AI-quantified plaque analysis by drawing parallels to how oncology and gastroenterology approach early detection. 1778168340000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/05/14/27/accel-lite-05may2026 In this interview, William E. Boden MD, FACC and Roger S. Blumenthal, MD, FACC discuss ‘Lower LDL-C for Longer? Defining the Optimal Timing and Intensity of Rx’. 1777991400000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/01/01/JACC-in-a-Flash Featured topics and Editors' Picks from all of ACC's JACC Journals. 1777637400000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/01/01/Journal-Wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC. 1777637340000 Articles and Stories /Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career! 1777629480000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/27/19/07/accel-lite-28apr2026 In this interview, Kim Allan Williams, Sr., MD, MACC and Roger S. Blumenthal, MD, FACC discuss key takeaways from the 2026 Dyslipidemia Guideline. 1777392000000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/27/19/07/Implications-of-ACC26-Prevention-Trials-For-Future-Guidelines The VESALIUS-CV trial primary prevention analysis was a prespecified evaluation of use of evolocumab in 3,655 trial participants who had elevated LDL cholesterol (LDL-C) values but no evidence of significant atherosclerotic cardiovascular disease (ASCVD), defined as no prior revascularization, no arterial stenosis... 1777391340000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/27/15/01/cardiacast_27apr2026 In this episode, Drs. Christie Ballantyne and Eugenia Gianos discuss updates regarding the management of dyslipidemia released in new guidelines from the ACC and AHA Joint Committee on Clinical Practical Guidelines. 1777302300000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/04/17/16/45/ApoB Appropriate Apolipoprotein B (apoB) may be used as a cost-effective marker to improve population health and guide lipid-lowering therapy (LLT) in primary prevention, according to a computer simulation study published April 8 in JAMA. 1776445740000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/15/17/13/Sex-Specific-Differences-in-CVD-Risk-Factors-in-South-Korea In adults with cardiovascular disease in South Korea, the rates of awareness and treatment of key cardiovascular risk factors were higher in women than in men, but they had lower rates of risk factor control, particularly for hypertension and hypercholesterolemia... 1776367320000 Articles and Stories